Vertex Pharmaceuticals Stocks List
Related Industries: Biotechnology
Related Stock Lists:
Anilides
Autoimmune Disease
Breakthrough Therapy
Chemical Compounds
Cyclopropanes
Cystic Fibrosis
Genotype
HCV
HCV Infection
Hepatitis C
Hepatitis C Virus
Infection
Influenza
Nasdaq 100
Organic Compounds
Organofluorides
S&P 500
Treatment Of Autoimmune Disease
Treatment Of Cystic Fibrosis
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBH | B | Market Vectors Biotech ETF | 10.59 | |
IBBQ | A | Invesco Nasdaq Biotechnology ETF | 9.21 | |
IBB | B | iShares Nasdaq Biotechnology Index Fund | 9.2 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 7.21 | |
BIB | B | ProShares Ultra Nasdaq Biotechnology | 6.19 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Anilides
Autoimmune Disease
Breakthrough Therapy
Chemical Compounds
Cyclopropanes
Cystic Fibrosis
Genotype
HCV
HCV Infection
Hepatitis C
Hepatitis C Virus
Infection
Influenza
Nasdaq 100
Organic Compounds
Organofluorides
S&P 500
Treatment Of Autoimmune Disease
Treatment Of Cystic Fibrosis
- Vertex Pharmaceuticals
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England.
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles